HIV trials in Netherlands
7 of 13 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 13 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleStudy of Lenacapavir, Teropavimab, and Zinlirvimab in Virologically Suppressed Adults With HIV-1 on Stable Oral Treatment Regimens
- Where
- Amsterdam, Rotterdam
- Age
- 18 years and over
- People
- 183 worldwide
- Run by
- Gilead Sciences Inc.
See details and how to join2025-524336-19-00 - Phase 3Taking peopleStudy of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy
- Where
- Leiden, Utrecht
- Age
- 18 years and over
- People
- 183 worldwide
- Run by
- Gilead Sciences Inc.
See details and how to join2025-524335-39-00 - No phaseTaking people#AWARE.HIV Europe: Supporting Healthcare Professionals to Find Undiagnosed HIV in European Hospitals: An Effectiveness-implementation Trial.
- Where
- Arnhem, Eindhoven, Groningen, Rotterdam, The Hague
- Age
- 18 years and over
- People
- 5,200 worldwide
- Run by
- Casper Rokx
See details and how to joinNCT06900829 - Phase 1/2Not yet taking people in NetherlandsCombining Latency Reversing Agents to Address the HIV Reservoir
- Where
- Amsterdam, Nijmegen, Rotterdam, Utrecht
- Age
- 18 years and over
- People
- 30
- Run by
- Erasmus Medical Center
See details and how to joinNCT07384624 · EU 2026-525211-14-00 - Phase 2Taking peopleResearch into topiramate to remove the hidden HIV in people living with HIV taking HIV treatment
- Where
- Rotterdam
- Age
- 18 years and over
- People
- 12
- Run by
- Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
See details and how to joinNCT06282783 · EU 2024-511532-27-00 - Phase 4Taking peopleThe impact of vaccine platform, age and HIV infection on germinal centre formation.
- Where
- Leiden
- Age
- 18 years and over
- People
- 75
- Run by
- Academisch Ziekenhuis Leiden
See details and how to join2023-510354-16-00 - Phase 2Taking peopleA Randomised Placebo Controlled Trial of ART Plus Dual Long-acting HIV-specific Broadly Neutralising Antibodies (bNAbs).
- Where
- Rotterdam
- Age
- 18 years to 60 years
- People
- 72 worldwide
- Run by
- Imperial College London
See details and how to joinNCT04319367 · EU 2024-514564-13-00